We are live on ! Find out more
VTAK icon

Catheter Precision
VTAK

10 hedge funds and large institutions have $57.2K invested in Catheter Precision in 2026 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

1.83% less ownership

Funds ownership: 4.32% → 2.5% (-1.8%)

17% less funds holding

Funds holding: 12 → 10 (-2)

44% less capital invested

Capital invested by funds: $103K → $57.2K (-$45.7K)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
10
Holders Change
-2
Holders Change %
-16.67%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$15.5K
2
Osaic Holdings
Osaic Holdings
Arizona
+$8.1K
3
VF
Virtu Financial
New York
+$6.06K
4
TRCT
Tower Research Capital (TRC)
New York
+$5.28K
5
Citigroup
Citigroup
New York
+$20

Top Sellers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
-$33.9K
2
Millennium Management
Millennium Management
New York
-$13.3K
3
Jane Street
Jane Street
New York
-$11.5K
4
HF
HRT Financial
New York
-$11K

VTAK Hedge Fund Activity: Q2 2026 in Review

10 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q2 2026, worth a combined $57.2K — down 44% from $103K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of VTAK and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 4 added.

The largest buyer was UBS Group, adding an estimated $15.5K. The largest seller was Geode Capital Management, cutting an estimated $33.9K.

  • 10 institutional investors held Catheter Precision (VTAK) as of Q2 2026, down from 12 in Q1 2026.
  • Funds reported $57.2K of Catheter Precision stock for Q2 2026, down 44% quarter-over-quarter.
  • 1 fund opened new Catheter Precision positions in Q2 2026 and 3 closed out, a net change of -2 holders.
  • The largest Catheter Precision buyer in Q2 2026 was UBS Group, an estimated $15.5K added.
  • The largest Catheter Precision seller in Q2 2026 was Geode Capital Management, an estimated $33.9K sold.

Based on aggregated 13F filings for Q2 2026.